Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro

MLA

Henie M. J. Roelofs, et al. “Infliximab Exerts No Direct Hepatotoxic Effect on HepG2 Cells in Vitro.” Digestive Diseases and Sciences, vol. 57, Jan. 2012, pp. 1604–08. EBSCOhost, https://doi.org/10.1007/s10620-012-2159-7.

APA

Henie M. J. Roelofs, Wilbert H.M. Peters, Hilbert S. de Vries, Rene H. M. te Morsche, Dirk J. de Jong, & Tineke de Heij. (2012). Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro. Digestive Diseases and Sciences, 57, 1604–1608. https://doi.org/10.1007/s10620-012-2159-7

Chicago

Henie M. J. Roelofs, Wilbert H.M. Peters, Hilbert S. de Vries, Rene H. M. te Morsche, Dirk J. de Jong, and Tineke de Heij. 2012. “Infliximab Exerts No Direct Hepatotoxic Effect on HepG2 Cells in Vitro.” Digestive Diseases and Sciences 57 (January): 1604–8. doi:10.1007/s10620-012-2159-7.